REVAXIS is an inactivated vaccine designed to provide immunization against three serious diseases: diphtheria, tetanus, and poliomyelitis (polio). It is typically administered as an injection and is used as a booster vaccine in individuals who have previously been vaccinated against these diseases. The vaccine works by stimulating the body's immune system to produce antibodies against the toxins produced by the bacteria responsible for diphtheria and tetanus, as well as against the poliovirus, thereby providing protection against these infections. REVAXIS is commonly used in booster vaccination programs and is suitable for use in both adults and children, according to the specific guidelines and recommendations of health authorities.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.